Drug bests cystic-fibrosis mutation

Heidi Ledford

Nature, 2012, vol. 482, issue 7384, 145-145

Abstract: First treatment to tackle protein behind the disease wins approval — but only a small fraction of patients will benefit.

Date: 2012
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/482145a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:482:y:2012:i:7384:d:10.1038_482145a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/482145a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().